258 related articles for article (PubMed ID: 30722819)
1. [Tumor treating fields in cancer treatment in Denmark].
Korshøj AR; Lukacova S; Mikic N; Stigaard Cortnum SO; Lassen-Ramshad Y; Guldberg TL; Severinsen KE; Thielscher A; Poulsen FR; Hedemann Sørensen JC; von Oettingen GB
Ugeskr Laeger; 2019 Jan; 181(5):. PubMed ID: 30722819
[TBL] [Abstract][Full Text] [Related]
2. [Tumor treating fields in cancer treatment in Denmark].
Korshøj AR; Lukacova S; Mikic N; Cortnum SOS; Lassen-Ramshad Y; Guldberg TL; Severinsen KE; Thielscher A; Poulsen FR; Sørensen JCH; Oettingen GBV
Ugeskr Laeger; 2019 Oct; 181(20A):. PubMed ID: 31610842
[TBL] [Abstract][Full Text] [Related]
3. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
[TBL] [Abstract][Full Text] [Related]
4. Tumour treating fields therapy for glioblastoma: current advances and future directions.
Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
[TBL] [Abstract][Full Text] [Related]
5. First steps to creating a platform for high throughput simulation of TTFields.
Hershkovich HS; Bomzon Z; Wenger C; Urman N; Chaudhry A; Garcia-Carracedo D; Kirson ED; Weinberg U; Wassermann Y; Palti Y
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2357-2360. PubMed ID: 28268799
[TBL] [Abstract][Full Text] [Related]
6. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy.
Pohling C; Nguyen H; Chang E; Schubert KE; Nie Y; Bashkirov V; Yamamoto V; Zeng Y; Stupp R; Schulte RW; Patel CB
Bioelectrochemistry; 2023 Feb; 149():108287. PubMed ID: 36306728
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.
Riley MM; San P; Lok E; Swanson KD; Wong ET
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058901
[TBL] [Abstract][Full Text] [Related]
8. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
[TBL] [Abstract][Full Text] [Related]
9. Tumor treating fields: a novel treatment modality and its use in brain tumors.
Hottinger AF; Pacheco P; Stupp R
Neuro Oncol; 2016 Oct; 18(10):1338-49. PubMed ID: 27664860
[TBL] [Abstract][Full Text] [Related]
10. Rationale and Background on Tumor-Treating Fields for Glioblastoma.
Schwartz MA; Onuselogu L
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S20-4. PubMed ID: 27668387
[TBL] [Abstract][Full Text] [Related]
11. Tumor treating fields: a new frontier in cancer therapy.
Davies AM; Weinberg U; Palti Y
Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]).
Shams S; Patel CB
J Mol Cell Biol; 2022 Dec; 14(8):. PubMed ID: 35973687
[TBL] [Abstract][Full Text] [Related]
13. AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields).
Shteingauz A; Porat Y; Voloshin T; Schneiderman RS; Munster M; Zeevi E; Kaynan N; Gotlib K; Giladi M; Kirson ED; Weinberg U; Kinzel A; Palti Y
Cell Death Dis; 2018 Oct; 9(11):1074. PubMed ID: 30341282
[TBL] [Abstract][Full Text] [Related]
14. Tumor Treating Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors.
Benson L
Semin Oncol Nurs; 2018 May; 34(2):137-150. PubMed ID: 29631935
[TBL] [Abstract][Full Text] [Related]
15. Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.
Jo Y; Kim EH; Sai S; Kim JS; Cho JM; Kim H; Baek JH; Kim JY; Hwang SG; Yoon M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469352
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy.
Saria MG; Kesari S
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S9-S13. PubMed ID: 27668388
[TBL] [Abstract][Full Text] [Related]
17. The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study.
Wenger C; Salvador R; Basser PJ; Miranda PC
Phys Med Biol; 2015 Sep; 60(18):7339-57. PubMed ID: 26350296
[TBL] [Abstract][Full Text] [Related]
18. Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields).
Porat Y; Giladi M; Schneiderman RS; Blat R; Shteingauz A; Zeevi E; Munster M; Voloshin T; Kaynan N; Tal O; Kirson ED; Weinberg U; Palti Y
J Vis Exp; 2017 May; (123):. PubMed ID: 28518093
[TBL] [Abstract][Full Text] [Related]
19. Tumor Treating Fields in Neuro-Oncological Practice.
Mrugala MM; Ruzevick J; Zlomanczuk P; Lukas RV
Curr Oncol Rep; 2017 Aug; 19(8):53. PubMed ID: 28664468
[TBL] [Abstract][Full Text] [Related]
20. The Mechanisms of Action of Tumor Treating Fields.
Moser JC; Salvador E; Deniz K; Swanson K; Tuszynski J; Carlson KW; Karanam NK; Patel CB; Story M; Lou E; Hagemann C
Cancer Res; 2022 Oct; 82(20):3650-3658. PubMed ID: 35839284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
